Unpublished clinical trials with sumatriptan

The Lancet

Volumn 374, Issue 9700, 2009, Pages 1501-1502

  Tfelt Hansen, Peer Carsten ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLIZINE; CAFERGOT; CAFFEINE; CODEINE PHOSPHATE; CYCLIZINE; ERGOTAMINE; ERGOTAMINE TARTRATE; METOCLOPRAMIDE; PARACETAMOL; SUMATRIPTAN;

CLINICAL TRIAL; DISEASE SEVERITY; DRUG EFFICACY; FRANCE; GENERAL PRACTICE; GERMANY; HEADACHE; HUMAN; LETTER; MEDICAL SOCIETY; MIGRAINE; OUTCOME ASSESSMENT; PRIORITY JOURNAL;

EID: 70350498807     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(09)61906-1     Document Type: Letter

References (4)

1. Tfelt-Hansen P., Saxena P.R., Dahlof C., et al. Ergotamine in the acute treatment of migraine-a review and European Consensus. Brain 123 (2000) 9-18
2. Multinational Oral Sumatriptan and, and Cafergot Comparative Study Group. A randomized, double-blind comparison of sumatriptan in the acute treatment of migraine. Eur Neurol 31 (1991) 314-322
3. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group. A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. Eur Neurol 32 (1992) 177-184
4. Ethics Subcommittee of the International Headache Society. Ethical issues arising from commercial sponsorship and from relationship with the pharmaceutical industry-report and recommendations of the Ethics Committee of the International Headache Society. Cephalalgia 28 suppl 3 (2008) 1-25